Afatinib Therapy for Brain Metastases Aggravated by a Reduction in the Dose of Erlotinib Due to the Development of Hepatotoxicity.
about
Afatinib Therapy for Brain Metastases Aggravated by a Reduction in the Dose of Erlotinib Due to the Development of Hepatotoxicity.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Afatinib Therapy for Brain Met ...... Development of Hepatotoxicity.
@en
Afatinib Therapy for Brain Met ...... Development of Hepatotoxicity.
@nl
type
label
Afatinib Therapy for Brain Met ...... Development of Hepatotoxicity.
@en
Afatinib Therapy for Brain Met ...... Development of Hepatotoxicity.
@nl
prefLabel
Afatinib Therapy for Brain Met ...... Development of Hepatotoxicity.
@en
Afatinib Therapy for Brain Met ...... Development of Hepatotoxicity.
@nl
P2093
P2860
P1433
P1476
Afatinib Therapy for Brain Met ...... Development of Hepatotoxicity
@en
P2093
Akimasa Sekine
Koji Okudela
Satoshi Ikeda
Tae Iwasawa
Takashi Ogura
Terufumi Kato
Tomohisa Baba
Yumie Yamanaka
P2860
P304
P356
10.2169/INTERNALMEDICINE.8638-16
P577
2017-09-25T00:00:00Z